Clinicopathologic factors | Cases | Expression of VEGF-C | p value | Expression of VEGFR-3 | p value | ||
Positive | Negative | Positive | Negative | ||||
Gender |
|
|
| 0.231 |
|
| 0.228 |
Male | 139 | 80 | 59 |
| 50 | 89 |
|
Female | 47 | 22 | 25 |
| 12 | 35 |
|
Age |
|
|
| 0.849 |
|
| 0.329 |
≤60 | 108 | 60 | 48 |
| 33 | 75 |
|
>60 | 78 | 43 | 35 |
| 30 | 48 |
|
Tumor location |
|
|
| 0.061 |
|
| 0.628 |
Upper stomach 1/3 | 42 | 32 | 10 |
| 17 | 25 |
|
Middle stomach 1/3 | 33 | 12 | 21 |
| 11 | 22 |
|
Lower stomach 1/3 | 111 | 59 | 52 |
| 35 | 76 |
|
Gross type |
|
|
| 0.012 |
|
| 0.777 |
I | 14 | 10 | 4 |
| 6 | 8 |
|
II | 59 | 27 | 32 |
| 18 | 41 |
|
III | 96 | 61 | 35 |
| 36 | 60 |
|
IV | 17 | 5 | 12 |
| 3 | 14 |
|
Tumor depth |
|
|
| 0.028 |
|
| 0.122 |
pT1 | 40 | 17 | 23 |
| 10 | 30 |
|
pT2 | 49 | 24 | 25 |
| 13 | 36 |
|
pT3 - 4 | 97 | 62 | 35 |
| 39 | 58 |
|
Differentiation degree |
|
|
| 0.614 |
|
| 0.244 |
High | 16 | 7 | 9 |
| 4 | 12 |
|
Medium | 57 | 30 | 27 |
| 16 | 41 |
|
Low | 113 | 65 | 48 |
| 43 | 70 |
|
Clinical stage |
|
|
| 0.002 |
|
| 0.072 |
I | 52 | 24 | 28 |
| 14 | 38 |
|
II | 41 | 15 | 26 |
| 10 | 31 |
|
III | 70 | 47 | 23 |
| 29 | 41 |
|
IV | 23 | 17 | 6 |
| 11 | 12 |
|
Lymph node metastasis |
|
|
| 0.0001 |
|
| 0.002 |
Positive | 96 | 71 | 25 |
| 43 | 53 |
|
Negative | 90 | 31 | 59 |
| 19 | 71 |
|